8th Jul 2016 06:45
LONDON (Alliance News) - Deltex Medical Group PLC on Friday said revenue in the US and International divisions had continued to grow in the first half of 2016, but the UK market remains weak.
The company, which makes oesophageal Doppler monitoring probes, said its expansion plans in the US remain on track, with good hospital pipeline progress made in the first half. US probe revenue in the six months to the end of June grew 40%, it said.
International probe revenue grew 11%, Deltex said, with continued growth in markets such as France, Scandinavia and Peru, where Deltex is focusing its energies. Progress was also made in South Korea and the group received good results from trials held in Spain.
The UK market, however, remains weak, with probe revenue falling 36%. Deltex intends to launch new products in this market in the second half.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Deltex Medical